🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In recognition of National Cancer Research Month, today we are highlighting the work of Mehdi Mollapour, PhD and celebrating his accomplishments in the realm of kidney cancer research. Read about Mehdi Mollapour PhD below. ⤵

Incredibly proud of Neeraj Agarwal, MD, FASCO for publishing #TALAPRO2 in The Lancet. It’s work deserving of publication in this IF>200 journal - biomarker work is rigorous & outcome + in ITT & biomarker based subgroups. This study is in a lineage of key trials Neeraj has led starting w SWOG Cancer Research Network

Throwback Thursday: Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable PCa buff.ly/2u2tIcy Hanan Goldberg Rachel Glicksman Thenappan (Thenu) Chandrasekar, MD Zach Klaassen Christopher Wallis (he/him/his) Ali Hosni Girish Kulkarni Nathan Perlis Theo van der Kwast neil fleshner Alejandro (Ale) Berlin

It is always a pleasure to discuss PCa with Zach Klaassen . Thanks for making it so enjoyable & thanks to UroToday.com for inviting me to talk about nmCRPC in this constantly evolving space. Lots of questions remain regarding imaging, diagnosis, treatment and education.

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Proud of our recent Nature Urology review with great input by brilliant Roger Li & Petros Grivas exploring a rare & important entity of metastatic NMIBC. More biomarker driven research will help diagnose these more appropriately.Upstate Cancer Center Upstate Medical University Upstate Research

So excited by our work with Hanan Goldberg Roger Li & other great colleagues! Appreciate the chance to collaborate with you all! Fred Hutch Cancer Center Nicole D. Fleming MD OncoAlert IBCG Bladder Cancer Advocacy Network World Bladder Cancer Patient Coalition Dimitra R. Bakaloudi MD, MS, MPA Ashish M. Kamat, MD, MBBS Philippe spiess Sarah P. Psutka MD MS

Wonderful collaboration with Hanan Goldberg Petros Grivas on an important topic Devastating situation for patients to develop metastases while on surveillance for #NMIBC We need to understand this disease process to better monitor our patients. Biomarkers will be the 🔑

[Paywall] In nature: Metastasis development in non-muscle-invasive bladder cancer, including from authors including @PGrivasMDPhd and @urogerlimd. Click to log into your account to read the article: nature.com/articles/s4158…

Care for patients with nonmetastatic castration-resistant #ProstateCancer. Hanan Goldberg Upstate Urology and Zach Klaassen Georgia Cancer Center discuss this evolving landscape and the impact of PSMA PET scans on diminishing this patient category. #WatchNow > bit.ly/3uZ9nJ1

Darolutamide + ADT improves outcomes in metastatic hormone-sensitive #ProstateCancer. Hanan Goldberg Upstate Urology joins Zach Klaassen Georgia Cancer Center discussing a case of a 71-year-old man with newly diagnosed #mHSPC, featuring an initial PSA of 271 and low-volume bone/lymph